decisionhealth Newsletters, Part B News - 2008 Issue 7 (July)
DEA e-prescribing proposal could make bonus hard to get
Subscribe or sign in to view the full article.
Article Overview
This article is about a DEA proposed rule on electronic prescribing, with emphasis on its potential impact on providers seeking e-prescribing incentives. It is relevant to physicians, medical group managers, compliance staff, and billing/coding professionals who track federal regulatory changes that affect prescribing workflows and incentive programs. The discussion focuses on the broad scope of the proposal, related administrative requirements, and the public comment process.
Why This Topic Matters
Federal prescribing rules can affect how practices implement e-prescribing and whether they remain eligible for incentive programs. Monitoring proposed DEA requirements helps organizations anticipate compliance and workflow changes.
What You Will Learn
- The general focus of a DEA proposal affecting e-prescribing of controlled substances
- Why the proposal may matter for participation in e-prescribing incentive programs
- What types of administrative and identity-verification requirements are being discussed
- How the public comment process fits into the rulemaking timeline
Who Should Read This
- Physicians
- Medical practice administrators
- Compliance officers
- Billing and coding professionals
- Healthcare consultants
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com